OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer
Clinical trial NCT07153705 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07153705
- Sponsor
- Beihua Kong
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.